Lin et al. showed that the LPS-ligand of TLR4 activated the STAT3 pathway which activated the COX-2/PGE2 signaling axis, leading to hepatoma cell proliferation, and increasing drug resistance and tumor invasiveness (21). The gene discussed is PTGS2; the disease is hepatocellular carcinoma.